-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-067 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-067 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST-067 in Triple-Negative Breast Cancer (TNBC) Drug Details: ST-067 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-067 in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-067 in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST-067 in Cutaneous Squamous Cell Carcinoma (cSCC) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tecovirimat in Monkeypox
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tecovirimat in Monkeypox report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tecovirimat in Monkeypox Drug Details: Tecovirimat (Tpoxx / ST-246) is an antiviral...
-
Product Insights
NewQuarterly Beer & Ale pricing trends in France
Empower your strategies with our Quarterly Beer & Ale pricing trends in France report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBAC-01 in Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBAC-01 in Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CBAC-01 in Stroke Drug Details: CordSTEM-ST is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SCP-776 in Myocardial Infarction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SCP-776 in Myocardial Infarction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SCP-776 in Myocardial Infarction Drug Details: SCP-776 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST316 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST316 in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST316 in Metastatic Breast Cancer Drug Details: ST-316 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ozuriftamab Vedotin in Recurrent Head And Neck Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ozuriftamab Vedotin in Recurrent Head And Neck Squamous Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ozuriftamab Vedotin in Recurrent Head...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ozuriftamab Vedotin in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ozuriftamab Vedotin in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ozuriftamab Vedotin in Oropharyngeal Cancer Drug Details: BA-3021 is under...